Efficacy and Safety of Reduqing Granules in the Treatment of Common Cold with Wind-heat Syndrome: a Randomized, Double-blind, Double-dummy, Positive-controlled Trial

Overview

Journal J Tradit Chin Med

Date 2018 Jul 2

PMID 29960290

Citations 6

Authors

Yanjiao Ma

Zhongyi Zhang

Lianbo Wei

Shuai He

Xun Deng

Aimin Ji

Benjie Zhou

Deqi Jiang

Mingxing Li

Yong Wang

Affiliations

Soon will be listed here.

Abstract

Objective: To assess the efficacy and safety of Reduqing granules in patients with common cold with wind-heat syndrome (CCWHS).

Methods: A randomized, double-blind, double-dummy, parallel, positive- controlled trial included 72 CCWHS patients was performed. The participants were randomly assigned to two groups, Reduqing (RDQ) group and Lianhuaqingwen (LHQW) group, in a 1:1 ratio. Patients in RDQ group received Reduqing granules and dummy Lianhuaqingwen capsules three times a day and patients in LHQW group received Lianhuaqingwen capsules and dummy Reduqing granules three times daily. The duration of treatment and follow-up were four days.

Results: There were no statistically significant differences in total markedly effective rate and total effective rate between RDQ group and LHQW group after treatment. Traditional Chinese Medicine (TCM) symptom score was significantly reduced after treatment in RDQ group, as well as in LHQW group. However, the difference of change in TCM symptom score between two groups was not statistically significant (P > 0.05). There were no significant differences between two groups in the median time to fever relief [RDQ group (4 ± 8) h vs LHQW group (4 ± 5) h] or the median time to fever clearance (RDQ group 47 h vs LHQW 36 h). No serious adverse events were reported during the study.

Conclusion: Compared with Lianhuaqingwen capsules, Reduqing granules achieved similar therapeutic effect in the treatment of CCWHS and no drug-related adverse events were reported during the study. Therefore, Reduqing granules might be effective and safe in the treatment of CCWHS.

Citing Articles

Efficacy and safety of herbal medicine (Binafuxi granules) for the common cold with fever: A multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.

Liu X, Min J, She B, Chen Y, Li J, Huang L Integr Med Res. 2023; 12(3):100956.

PMID: 37359288 PMC: 10285547. DOI: 10.1016/j.imr.2023.100956.

Herbal Granules of Heat-Clearing and Detoxifying for Children with Mild Hand, Foot, and Mouth Disease: A Bayesian Network Meta-Analysis.

Sheng Y, Liu X, Wang Q, Zhang Y, Huang L, Hu D Evid Based Complement Alternat Med. 2022; 2022:6818406.

PMID: 35677377 PMC: 9168089. DOI: 10.1155/2022/6818406.

Molecular Mechanism of Dayuan Decoction in the Treatment of Fever Based on Network Pharmacology.

Ye T Comput Math Methods Med. 2022; 2022:7422383.

PMID: 35371275 PMC: 8975675. DOI: 10.1155/2022/7422383.

Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.

Li L, Zhang Z, Zhou W, Chen J, Jin H, Fang H Biomed Pharmacother. 2021; 130:110641.

PMID: 34321172 PMC: 7437484. DOI: 10.1016/j.biopha.2020.110641.

Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening.

Chen X, Wu Y, Chen C, Gu Y, Zhu C, Wang S Acta Pharm Sin B. 2020; 11(1):222-236.

PMID: 33072499 PMC: 7547831. DOI: 10.1016/j.apsb.2020.10.002.

References

Taverner D, Latte G . WITHDRAWN: Nasal decongestants for the common cold. Cochrane Database Syst Rev. 2009; (2):CD001953. PMC: 10759274. DOI: 10.1002/14651858.CD001953.pub4. View

Kenealy T, Arroll B . Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2013; (6):CD000247. PMC: 7044720. DOI: 10.1002/14651858.CD000247.pub3. View

Mossad S . Treatment of the common cold. BMJ. 1998; 317(7150):33-6. PMC: 1113448. DOI: 10.1136/bmj.317.7150.33. View

Hemila H, Chalker E . Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013; (1):CD000980. PMC: 8078152. DOI: 10.1002/14651858.CD000980.pub4. View

Hayward G, Thompson M, Perera R, Del Mar C, Glasziou P, Heneghan C . Corticosteroids for the common cold. Cochrane Database Syst Rev. 2015; (10):CD008116. PMC: 8734596. DOI: 10.1002/14651858.CD008116.pub3. View

Hsiao C, Cherry D, Beatty P, Rechtsteiner E . National Ambulatory Medical Care Survey: 2007 summary. Natl Health Stat Report. 2010; (27):1-32. View

Mackay I . Human rhinoviruses: the cold wars resume. J Clin Virol. 2008; 42(4):297-320. PMC: 7108405. DOI: 10.1016/j.jcv.2008.04.002. View

Duan Z, Jia Z, Zhang J, Liu S, Chen Y, Liang L . Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial. Chin Med J (Engl). 2011; 124(18):2925-33. View

Hatton R, Winterstein A, McKelvey R, Shuster J, Hendeles L . Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Ann Pharmacother. 2007; 41(3):381-90. DOI: 10.1345/aph.1H679. View

10.

Simancas-Racines D, Guerra C, Hidalgo R . Vaccines for the common cold. Cochrane Database Syst Rev. 2013; (6):CD002190. DOI: 10.1002/14651858.CD002190.pub4. View

11.

Kiyohara H, Ichino C, Kawamura Y, Nagai T, Sato N, Yamada H . Patchouli alcohol: in vitro direct anti-influenza virus sesquiterpene in Pogostemon cablin Benth. J Nat Med. 2011; 66(1):55-61. DOI: 10.1007/s11418-011-0550-x. View

12.

Dong L, Xia J, Gong Y, Chen Z, Yang H, Zhang J . Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease. Evid Based Complement Alternat Med. 2014; 2014:637969. PMC: 4058171. DOI: 10.1155/2014/637969. View

13.

Rerksuppaphol S, Rerksuppaphol L . Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatr Int. 2012; 54(5):682-7. DOI: 10.1111/j.1442-200X.2012.03647.x. View

14.

Fashner J, Ericson K, Werner S . Treatment of the common cold in children and adults. Am Fam Physician. 2012; 86(2):153-9. View

15.

Vitetta L, Coulson S, Beck S, Gramotnev H, Du S, Lewis S . The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction (Lf/IgF) for the common cold: a double blind randomized study. Complement Ther Med. 2013; 21(3):164-71. DOI: 10.1016/j.ctim.2012.12.006. View

16.

Roll S, Nocon M, Willich S . Reduction of common cold symptoms by encapsulated juice powder concentrate of fruits and vegetables: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2010; 105(1):118-22. PMC: 3023145. DOI: 10.1017/S000711451000317X. View

17.

Bachert C, Chuchalin A, Eisebitt R, Netayzhenko V, Voelker M . Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour.... Clin Ther. 2005; 27(7):993-1003. DOI: 10.1016/j.clinthera.2005.06.002. View

18.

Eccles R, Martensson K, Chen S . Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold. Curr Med Res Opin. 2010; 26(4):889-99. DOI: 10.1185/03007991003648015. View

19.

Kollar C, Schneider H, Waksman J, Krusinska E . Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common cold. Clin Ther. 2007; 29(6):1057-70. DOI: 10.1016/j.clinthera.2007.05.021. View

20.

Worrall G . Common cold. Can Fam Physician. 2011; 57(11):1289-90. PMC: 3215607. View